GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

GIP[3-30]NH2

Company
Frederikke Koefoed-Hansen
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
3 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

3 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Find a Clinical Trial Near Me

See recruiting studies for GIP[3-30]NH2 and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT05375968

    Splanchnic Venous Capacitance in Postural Tachycardia Syndrome

    Not yet reported Vanderbilt University Medical Center 50 participants Est. completion 2028-06-01 1 site
    Other conditions: Postural Tachycardia Syndrome (POTS)
    View official trial listing →
  • Recruiting NCT NCT06934473

    Effects of Endogenous GIP on Postprandial Blood Pressure in Healthy Individuals

    Not yet reported University Hospital, Gentofte, Copenhagen 16 participants Est. completion 2026-01-31 2 sites
    Other conditions: Bloodpressure
    View official trial listing →
  • Recruiting NCT NCT07019519

    POTS-FLOW: Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patients With POTS

    Not yet reported University of Copenhagen 30 participants Est. completion 2026-09-30 1 site
    Other conditions: Postural Orthostatic Tachycardia Syndrome (POTS), Healthy
    View official trial listing →
  • Completed NCT NCT03702660

    Effect of GIP After a Meal in Patients With Type 2 Diabetes

    Not yet reported University Hospital, Gentofte, Copenhagen 10 participants Est. completion 2018-01-23 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03770910

    The Effect of GIP(3-30)NH2

    Not yet reported University Hospital, Gentofte, Copenhagen 8 participants Est. completion 2019-12-01 2 sites
    Other conditions: Endocrine - Other
    View official trial listing →
  • Completed NCT NCT04228484

    The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 Diabetes

    Not yet reported University Hospital, Gentofte, Copenhagen 15 participants Est. completion 2022-10-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05177653

    Separate and Combined Extrapancreatic Effects of the Incretin Hormones

    Not yet reported University Hospital, Gentofte, Copenhagen 13 participants Est. completion 2023-03-03 1 site
    Other conditions: Pancreatectomy; Hyperglycemia
    View official trial listing →
  • Completed NCT NCT05391581

    The Role of GIP and GLP-2 in Postprandial Splanchnic Blood Flow Distribution and Metabolism

    Not yet reported University of Copenhagen 10 participants Est. completion 2023-02-07 1 site
    Other conditions: Blood Flow
    View official trial listing →
  • Enrolling by invitation NCT NCT06208904

    The Involvement of the Gut Hormone GIP in the Pathophysiology of Post Prandial Hypotension

    Not yet reported University Hospital, Gentofte, Copenhagen 18 participants Est. completion 2025-12-31 1 site
    Other conditions: PostPrandial Hypotension
    View official trial listing →
  • Status unknown NCT NCT06368752

    The Role of Endogenous GIP in Glycosis Metabolism During Fasting

    Not yet reported Frederikke Koefoed-Hansen 12 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT06426823

    The Role of GIP in Postprandial Splanchnic Blood Flow Distribution and Metabolism in Patients With Type 2 Diabetes

    Not yet reported University of Copenhagen 10 participants Est. completion 2026-03-16 1 site
    Other conditions: Blood Flow
    View official trial listing →
  • Enrolling by invitation NCT NCT07381816

    GastroFlow: Investigation of the Gastrointestinal Blood Flow in Patients With Postprandial Hypotension

    Not yet reported University of Copenhagen 30 participants Est. completion 2027-05-01 1 site
    Other conditions: Postprandial Hypotension, Healthy, Blood Flow
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.